Next Science (ASX: NXS) — Perfil da empresa, notícias e dados financeiros
Next Science develops innovative medical technologies to improve surgical outcomes and reduce surgical site infections.
NXS Next Science
Perfil da empresa
Next Science
Next Science (ASX:NXS) is a medical technology company developing innovative solutions to help improve surgical outcomes and reduce surgical site infections. The company's primary focus is the development and continued commercialisation of its proprietary XBIO™ technology to reduce the impact of biofilm-based infections in human health.
Resumo
Public AUParticipação acionária
2012Ano de fundação
102Funcionários
New South Wales, AustraliaSede
Carregando mapa...
Presença global
Operações
Todos os locais
Australia
Produtos e/ou serviços de Next Science
- XBIO™ technology: Next Science's flagship product is its XBIO™ technology, a platform technology that can be used to develop a range of products to treat and prevent biofilm-based infections.
- XPERIENCE: Designed for use in cleansing and removal of debris, including microorganisms from wounds.
- BLASTX: Antimicrobial Wound Gel provides wound management by maintaining a moist wound environment, which is conducive to wound healing. While in place, the antimicrobial properties of the gel inhibit the growth of microorganisms in the product.
- SURGX: Sterile Antimicrobial Gel conforms to the postoperative wound. The gel provides a moist wound environment conducive to healing.
- Bactisure: Wound Lavage is used to remove debris, including microorganisms, from wounds using pulsed lavage. It is a clear, colourless and low-odour solution.
equipe executiva do Next Science
- Dr. Matthew Franco MynttiFounder & CTO
- Mr. Jon SwansonChief Strategy Officer
- Daniel CanonVice President of Operations
- Francoise DixonHead of Investor Relations
- Mr. Robert BellSenior Vice President of North American Sales
- Ms. Gillian Maria Nairn AGIA, B.A., L.L.B., L.L.M., MAICDCompany Secretary
Histórico de dividendos
Dividendos por ação pagos pela Next Science, por ano fiscal.
| Ano fiscal | Intermediário | Final | Especial | Total |
|---|---|---|---|---|
| FY2026(até o momento) | — | — | — | A$0.1450 |
Principais indicadores financeiros
Resultados divulgados pela Next Science, em USD.
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 22,8 mi | -10,3 mi | -10,6 mi | |
| 22,2 mi | -16 mi | -24,5 mi | |
| 11,7 mi | -12,7 mi | -18,3 mi | |
| 8,9 mi | -9,5 mi | -9,3 mi |